ROS-triggered and regenerating anticancer nanosystem: An effective strategy to subdue tumor's multidrug resistance

Journal of Controlled Release

Volumn 196, Issue , 2014, Pages 370-383

  Su, Zhigui ^a   Chen, Minglei ^a   Xiao, Yanyu ^a   Sun, Minjie ^a   Zong, Li ^a   Asghar, Sajid ^a,c   Dong, Mei ^b   Li, Huipeng ^a   Ping, Qineng ^a   Zhang, Can ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Multidrug resistance; Reactive oxygen species; ROS triggered and regenerating; Targeted drug delivery nanosystem; Tumor microenvironment

Indexed keywords

DRUG DELIVERY; ESTERIFICATION; ESTERS; HYALURONIC ACID; OXYGEN; TISSUE REGENERATION; TUMORS;

MULTIDRUG RESISTANCE; REACTIVE OXYGEN SPECIES; ROS-TRIGGERED AND REGENERATING; TARGETED DRUG DELIVERY; TUMOR MICROENVIRONMENT;

NANOSYSTEMS;

ALPHA TOCOPHEROL; DOXORUBICIN; GLYCOL; HYALURONIC ACID; NANOCARRIER; REACTIVE OXYGEN METABOLITE; SUCCINIC ACID; TOCOFERSOLAN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; NANOMATERIAL; POLYMER; SUCCINATE DEHYDROGENASE (UBIQUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL LYSATE; CELL REGENERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; ENDOCYTOSIS; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; TUMOR MICROENVIRONMENT; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; HUMAN; MULTIDRUG RESISTANCE; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTRON TRANSPORT COMPLEX II; FEMALE; HUMANS; MICE; MICE, NUDE; NANOSTRUCTURES; POLYMERS; REACTIVE OXYGEN SPECIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84912063361     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.09.020     Document Type: Article

References (40)

1. Q. Yin, J. Shen, Z. Zhang, H. Yu, Y. Li, Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor, Adv. Drug Deliv. Rev. 65 (2013) 1699-1715.
2. S. Kunjachan, B. Rychlik, G. Storm, F. Kiessling, T. Lammers, Multidrug resistance: physiological principles and nanomedical solutions, Adv. Drug Deliv. Rev. 65 (2013) 1852-1865.
3. T. Minko, L. Rodriguez-Rodriguez, V. Pozharov, Nanotechnology approaches for personalized treatment of multidrug resistant cancers, Adv. Drug Deliv. Rev. 65 (2013) 1880-1895.
4. A.R. Kirtane, S.M. Kalscheuer, J. Panyam, Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities, Adv. Drug Deliv. Rev. 65 (2013) 1731-1747.
5. F. Wang, Y.C. Wang, S. Dou, M.H. Xiong, T.M. Sun, J. Wang, Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells, ACS Nano 5 (2011) 3679-3692.
6. Y.J. Lee, R. Graeser, F. Kratz, K.E. Geckeler, Paclitaxel-loaded polymer nanoparticles for the reversal of multidrug resistance in breast cancer cells, Adv. Funct. Mater. 21 (2011) 4211-4218.
7. Y.C. Wang, F. Wang, T.M. Sun, J. Wang, Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells, Bioconjug. Chem. 22 (2011) 1939-1945.
8. R. Yamada, M.B. Kostova, R.K. Anchoori, S. Xu, N. Neamati, S.R. Khan, Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery, Cancer Biol. Ther. 9 (2010) 192-203.
9. Q. Jiang, C. Song, J. Nangreave, X. Liu, L. Lin, D. Qiu, Z.G. Wang, G. Zou, X. Liang, H. Yan, B. Ding, DNA origami as a carrier for circumvention of drug resistance, J. Am. Chem. Soc. 134 (2012) 13396-133403.
10. K. Liang, G.K. Such, Z. Zhu, S.J. Dodds, A.P. Johnston, J. Cui, H. Ejima, F. Caruso, Engineering cellular degradation of multilayered capsules through controlled cross-linking, ACS Nano 6 (2012) 10186-10194.
11. J. Lai, B.P. Shah, E. Garfunkel, K.B. Lee, Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release, ACS Nano 7 (2013) 2741-2750.
12. Z. Luo, K. Cai, Y. Hu, J. Li, X. Ding, B. Zhang, D. Xu, W. Yang, P. Liu, Redox-responsive molecular nanoreservoirs for controlled intracellular anticancer drug delivery based on magnetic nanoparticles, Adv. Mater. 24 (2012) 431-435.
13. H. Kim, S. Kim, C. Park, H. Lee, H.J. Park, C. Kim, Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gate-keepers, Adv. Mater. 22 (2010) 4280-4283.
14. A. Albini, M.B. Sporn, The tumour microenvironment as a target for chemoprevention, Nat. Rev. Cancer 7 (2007) 139-147.
15. P.D. Ray, B.W. Huang, Y. Tsuji, Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell. Signal. 24 (2012) 981-990.
16. J. Wang, X. Sun, W. Mao, W. Sun, J. Tang, M. Sui, Y. Shen, Z. Gu, Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy, Adv. Mater. 25 (2013) 3670-3676.
17. S. Wadhwa, R.J. Mumper, Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy, J. Control. Release 158 (2012) 215-223.
18. M.H. Xiong, Y. Bao, X.J. Du, Z.B. Tan, Q. Jiang, H.X. Wang, Y.H. Zhu, J. Wang, Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment, ACS Nano 7 (2013) 10636-10645.
19. V.M. Geoffrey, H.P. Ji, Y.L. Kevin, S. Neetu, S. Christian, M. Rolf, E.B. Wolfgang, R. Erkki, J.S. Michael, N.B. Sangeeta, Nanoparticles that communicate in vivo to amplify tumour targeting, Nat. Mater. 10 (2011) 545-552.
20. E.M. Collnot, C. Baldes, M.F. Wempe, R. Kappl, J. Huttermann, J.A. Hyatt, K.J. Edgar, U.F. Schaefer, C.M. Lehr, Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity, Mol. Pharm. 4 (2007) 465-474.
21. J. Neuzil, T. Weber, N. Gellert, C. Weber, Selective cancer cell killing by alpha-tocopheryl succinate, Br. J. Cancer 84 (2001) 87-89.
22. H.J. Youk, E. Lee, M.K. Choi, Y.J. Lee, J.H. Chung, S.H. Kim, C.H. Lee, S.J. Lim, Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol, J. Control. Release 107 (2005) 43-52.
23. L.F. Dong, P. Low, J.C. Dyason, X.F. Wang, L. Prochazka, P.K. Witting, R. Freeman, E. Swettenham, K. Valis, J. Liu, R. Zobalova, J. Turanek, D.R. Spitz, F.E. Domann, I.E. Scheffler, S.J. Ralph, J. Neuzil, Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II, Oncogene 27 (2008) 4324-4335.
24. A.R. Lippert, G.C. Van de Bittner, C.J. Chang, Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems, Acc. Chem. Res. 44 (2011) 793-804.
25. J.A. Burdick, G.D. Prestwich, Hyaluronic acid hydrogels for biomedical applications, Adv. Mater. 23 (2011) 41-56.
26. M. Han, Q. Lv, X.J. Tang, Y.L. Hu, D.H. Xu, F.Z. Li, W.Q. Liang, J.Q. Gao, Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex, J. Control. Release 163 (2012) 136-144.
27. M.T. Peracchia, C. Vauthier, C. Passirani, P. Couvreur, D. Labarre, Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles, Life Sci. 61 (1997) 749-761.
28. C.A. Gay, J.M. Gebicki, Perchloric acid enhances sensitivity and reproducibility of the ferric-xylenol orange peroxide assay, Anal. Biochem. 304 (2002) 42-46.
29. H. Chen, S. Kim, L. Li, S. Wang, K. Park, J.X. Cheng, Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 6596-6601.
30. S. Zhao, W. Dai, B. He, J. Wang, Z. He, X. Zhang, Q. Zhang, Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms, J. Control. Release 158 (2012) 413-423.
31. Y. Xu, X.F. Jin, Q.N. Ping, J. Cheng, M.J. Sun, F. Cao, W.L. You, D.F. Yuan, A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery, J. Control. Release 146 (2010) 299-308.
32. K.E. Broaders, S. Grandhe, J.M. Frechet, A biocompatible oxidation-triggered carrier polymer with potential in therapeutics, J. Am. Chem. Soc. 133 (2011) 756-758.
33. Y. Cui, Y. Zhao, Y. Tian, W. Zhang, X. Lu, X. Jiang, Themolecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli, Biomaterials 33 (2012) 2327-2333.
34. J.H. Park, H.J. Cho, H.Y. Yoon, I.S. Yoon, S.H. Ko, J.S. Shim, J.H. Cho, K. Kim, I.C. Kwon, D.D. Kim, Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery, J. Control. Release 174 (2014) 98-108.
35. S. Harnisch, R.H. Muller, Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition, Eur. J. Pharm. Biopharm. 49 (2000) 41-46.
36. Z.G. Su, J.X. Niu, Y.Y. Xiao, Q.N. Ping, M.J. Sun, A.W. Huang, W.L. You, X.Y. Sang, D.F. Yuan, Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine, Mol. Pharm. 8 (2011) 1641-1651.
37. R. Cascella, E. Evangelisti, M. Zampagni, M. Becatti, G. D'Adamio, A. Goti, G. Liguri, C. Fiorillo, C. Cecchi, S-linolenoyl glutathione intake extends life-span and stress resistance via Sir-2.1 upregulation in Caenorhabditis elegans, Free Radic. Biol. Med. 73C (2014) 127-135.
38. B. Al-Lazikani, U. Banerji, P. Workman, Combinatorial drug therapy for cancer in the post-genomic era, Nat. Biotechnol. 30 (2012) 679-692.
39. E.M. Collnot, C. Baldes, U.F. Schaefer, K.J. Edgar, M.F. Wempe, C.M. Lehr, Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access, Mol. Pharm. 7 (2010) 642-651.
40. S. Febvay, D.M. Marini, A.M. Belcher, D.E. Clapham, Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption, Nano Lett. 10 (2010) 2211-2219.